Skip to main content
EyePoint, Inc. (EYPT)
NASDAQ: EYPT · Real-Time Price · USD
17.56
-0.30 (-1.68%)
At close: Feb 27, 2026, 4:00 PM EST
17.00
-0.56 (-3.19%)
After-hours: Feb 27, 2026, 7:45 PM EST

EyePoint Revenue

EyePoint had revenue of $966.00K in the quarter ending September 30, 2025, a decrease of -90.82%. This brings the company's revenue in the last twelve months to $42.34M, down -7.38% year-over-year. In the year 2024, EyePoint had annual revenue of $43.27M, down -5.97%.

Revenue (ttm)
$42.34M
Revenue Growth
-7.38%
P/S Ratio
34.34
Revenue / Employee
$256,600
Employees
165
Market Cap
1.45B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202443.27M-2.75M-5.97%
Dec 31, 202346.02M4.61M11.14%
Dec 31, 202241.40M4.47M12.09%
Dec 31, 202136.94M2.50M7.27%
Dec 31, 202034.44M14.07M69.10%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Monte Rosa Therapeutics 181.54M
AnaptysBio 169.47M
Immatics 99.45M
Vir Biotechnology 68.56M
Tango Therapeutics 66.50M
Zenas BioPharma 15.00M
Nanobiotix 11.93M
Capricor Therapeutics 11.13M
Revenue Rankings

EYPT News

More News